“…The vanilloid phytochemical 1 displays potent antineoplastic activity in multiple human cancers ,, and can improve the therapeutic efficacy of chemotherapeutic drugs and radiation therapy when used in combination. − Despite such promising applications, the development of 1 as a clinically useful anticancer drug has been limited by its unpleasant side effects. The administration of 1 causes skin redness, hyperalgesia, nausea, intense tearing in the eyes, conjunctivitis, blepharospasm (sustained, forced, and involuntary closing of the eyelids), vomiting, abdominal pain, stomach cramps, bronchospasm, and burning diarrhea in patients. − Clinical trials exploring the pain-relieving activity of 1 have shown that such side effects have resulted in patients discontinuing use of the drug.…”